Literature DB >> 28296132

Polyvalent 2D Entry Inhibitors for Pseudorabies and African Swine Fever Virus.

Benjamin Ziem1, Jessica Rahn2, Ievgen Donskyi1, Kim Silberreis3, Luis Cuellar1, Jens Dernedde3, Günther Keil2, Thomas C Mettenleiter2, Rainer Haag1.   

Abstract

African swine fever virus (ASFV) is one of the most dangerous viruses for pigs and is endemic in Africa but recently also spread into the Russian Federation and the Eastern border of the EU. So far there is no vaccine or antiviral drug available to curtail the infection. Thus, control strategies based on novel inhibitors are urgently needed. Another highly relevant virus infection in pigs is Aujeszky's disease caused by the alphaherpesvirus pseudorabies virus (PrV). This article reports the synthesis and biological evaluation of novel extracellular matrix-inspired entry inhibitors based on polyglycerol sulfate-functionalized graphene sheets. The developed 2D architectures bind enveloped viruses during the adhesion process and thereby exhibit strong inhibitory effects, which are equal or better than the common standards enrofloxacin and heparin as demonstrated for ASFV and PrV. Overall, the developed polyvalent 2D entry inhibitors are nontoxic and efficient nanoarchitectures, which interact with various types of enveloped viruses. Therefore they prevent viral adhesion to the host cell and especially target viruses that rely on a heparan sulfate-dependent cell entry mechanism.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  African swine fever virus; polyglycerol sulfate; pseudorabies virus; thermally reduced graphene oxide; virus entry inhibitor

Mesh:

Substances:

Year:  2017        PMID: 28296132     DOI: 10.1002/mabi.201600499

Source DB:  PubMed          Journal:  Macromol Biosci        ISSN: 1616-5187            Impact factor:   4.979


  8 in total

1.  Polysulfates Block SARS-CoV-2 Uptake through Electrostatic Interactions*.

Authors:  Chuanxiong Nie; Paria Pouyan; Daniel Lauster; Jakob Trimpert; Yannic Kerkhoff; Gergo Peter Szekeres; Matthias Wallert; Stephan Block; Anil Kumar Sahoo; Jens Dernedde; Kevin Pagel; Benedikt B Kaufer; Roland R Netz; Matthias Ballauff; Rainer Haag
Journal:  Angew Chem Int Ed Engl       Date:  2021-06-09       Impact factor: 16.823

2.  Inhibitor analysis revealed that clathrin-mediated endocytosis is involed in cellular entry of type III grass carp reovirus.

Authors:  Hao Wang; Weisha Liu; Meng Sun; Dubo Chen; Lingbing Zeng; Liqun Lu; Jing Xie
Journal:  Virol J       Date:  2018-05-24       Impact factor: 4.099

3.  Different Effects of His-Au NCs and MES-Au NCs on the Propagation of Pseudorabies Virus.

Authors:  Chenchen Feng; Puxian Fang; Yanrong Zhou; Lingzhi Liu; Liurong Fang; Shaobo Xiao; Jiangong Liang
Journal:  Glob Chall       Date:  2018-06-25

4.  Graphene Sheets with Defined Dual Functionalities for the Strong SARS-CoV-2 Interactions.

Authors:  Ievgen S Donskyi; Chuanxiong Nie; Kai Ludwig; Jakob Trimpert; Rameez Ahmed; Elisa Quaas; Katharina Achazi; Jörg Radnik; Mohsen Adeli; Rainer Haag; Klaus Osterrieder
Journal:  Small       Date:  2021-02-02       Impact factor: 13.281

Review 5.  Modification of carbon-based nanomaterials by polyglycerol: recent advances and applications.

Authors:  Zeinab Rafiee; Sakineh Omidi
Journal:  RSC Adv       Date:  2021-12-20       Impact factor: 3.361

6.  High antiviral activity of mercaptoethane sulfonate functionalized Te/BSA nanostars against arterivirus and coronavirus.

Authors:  Yanrong Zhou; Xiaohan Jiang; Ting Tong; Liurong Fang; Yuan Wu; Jiangong Liang; Shaobo Xiao
Journal:  RSC Adv       Date:  2020-04-07       Impact factor: 4.036

Review 7.  Progress of Research into Novel Drugs and Potential Drug Targets against Porcine Pseudorabies Virus.

Authors:  Mo Zhou; Muhammad Abid; Shinuo Cao; Shanyuan Zhu
Journal:  Viruses       Date:  2022-08-11       Impact factor: 5.818

Review 8.  Use of nanotechnology in combating coronavirus.

Authors:  Saee Gharpure; Balaprasad Ankamwar
Journal:  3 Biotech       Date:  2021-06-28       Impact factor: 2.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.